Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong
Vincent Wai-Sun Wong,
Grace Lai-Hung Wong,
Terry C F Yip,
Ronald Ching Wan Ma,
Andrea On Yan Luk,
Xinge Zhang,
Alice Pik Shan Kong
Affiliations
Vincent Wai-Sun Wong
Department of Medicine and Therapeutics, The Chinese University of Hong Kong Faculty of Medicine, Hong Kong Special Administrative Region, People’s Republic of China
Grace Lai-Hung Wong
Department of Medicine and Therapeutics, The Chinese University of Hong Kong Faculty of Medicine, Hong Kong Special Administrative Region, People’s Republic of China
Terry C F Yip
Department of Medicine and Therapeutics, The Chinese University of Hong Kong Faculty of Medicine, Hong Kong Special Administrative Region, People’s Republic of China
Ronald Ching Wan Ma
Department of Medicine and Therapeutics, The Chinese University of Hong Kong Faculty of Medicine, Hong Kong Special Administrative Region, People’s Republic of China
Andrea On Yan Luk
Department of Medicine and Therapeutics, The Chinese University of Hong Kong Faculty of Medicine, Hong Kong Special Administrative Region, People’s Republic of China
Xinge Zhang
Department of Medicine and Therapeutics, The Chinese University of Hong Kong Faculty of Medicine, Hong Kong Special Administrative Region, People’s Republic of China
Alice Pik Shan Kong
Department of Medicine and Therapeutics, The Chinese University of Hong Kong Faculty of Medicine, Hong Kong Special Administrative Region, People’s Republic of China
